Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

BRAZIL IS PROJECTED TO BE THE NEXT GLOBAL COVID-19 PANDEMIC EPICENTER

Pedro de Lemos Menezes, David M. Garner, Vitor E. Valenti
doi: https://doi.org/10.1101/2020.04.28.20083675
Pedro de Lemos Menezes
1University of Health Sciences of Alagoas, AL, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David M. Garner
2Cardiorespiratory Research Group, Department of Biological and Medical Sciences, Faculty of Health and Life Sciences, Oxford Brookes University, Headington Campus, Oxford, OX3 0BP, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vitor E. Valenti
3Autonomic Nervous System Center (CESNA), São Paulo State University, UNESP, Marilia, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: vitor.valenti@unesp.br
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Coronavirus disease 2019 (COVID-19) is a disease triggered by SARS-CoV-2 infection, which is related in the most recent pandemic situation, significantly affecting health and economic systems. In this study we assessed the death rate associated to COVID-19 in Brazil and the United States of America (USA) to estimate the probability of Brazil becoming the next pandemic epicenter. We equated data between Brazil and USA obtained through the Worldometer website (www.worldometer.info). Epidemic curves from Brazil and USA were associated and regression analysis was undertaken to predict the Brazilian death rate regarding COVID-19 in June. In view of data from April 9th 2020, death rates in Brazil follow a similar exponential increase to USA (r=0.999; p<0.001), estimating 64,310 deaths by June 9th 2020. In brief, our results demonstrated that Brazil follows an analogous progression of COVID-19 deaths cases when compared to USA, signifying that Brazil could be the next global epicenter of COVID-19. We highlight public strategies to decrease the COVID-19 outbreak.

INTRODUCTION

The Coronavirus disease 2019 (COVID-19) is a new disease that has developed into a global public health concern as it has rapidly extended worldwide. The transmission of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2), initiating COVID-19, has led to this urgent pandemic status (Angelos et al, 2020).

This disease initially appeared in Wuhan, China, which became the first epicenter (Nature, 2020). Next, when the cases were partially controlled in China, Europe became affected and was an added epicenter of COVID-19 (Nature, 2020). At present, the United States of America (USA) is the current pandemic epicenter with in excess of 700,000 COVID-19 cases, consistent with the Worldometer website (www.worldometer.info).

In this scenario, we understand that Brazil has the potential for a considerable increase in deaths related to COVID-19 (www.worldometer.info). We comprehend that Brazil has the likelihood to be the next pandemic epicenter of the disease. So, in this report, we aim to evaluate deaths associated to COVID-19 in Brazil and USA, so as to authenticate any likenesses between the countries.

METHODS

The mortality data for COVID-19, which occurred in Brazil and the USA, was obtained from the Worldometer website (www.worldometer.info).

Worldometer is managed by an international team of developers, researchers, and volunteers’ with the objective of providing global health statistics available in a challenging and time relevant format, to an audience world-wide. It is published by a small and independent digital media company located in the USA. They have no political, governmental, or corporate affiliations.

Deaths were estimated until the 31st day after the 5th death in both countries.

At first, a link was achieved between COVID-19 mortality in the USA, which is related to the Pandemic development process and is considered as the current pandemic epicenter. Temporal modifications were completed, enabling the comparison of data on the Cartesian x-axis, and the adjustment of the number of deaths for each 10,000,000 inhabitants, which allowed the procurement of data on the Cartesian y-axis.

To relate the mortality results between the two countries, the Bivariate correlation test was enforced and the degree of linear relationship was considered by the Spearman coefficient.

Formerly, there were some regressions to discover the best mathematical model which would allow the representation of the mortality estimation curve for COVID-19 in Brazil and USA. Whilst searching for the mathematical model that best fits the mortality estimation curves, the following models were evaluated: Linear, Logarithmic, Inverse, Quadratic, Cubic, Composite, S, Growth, Exponential and Logistic. For this estimate, a significance of alpha, (α) less than 0.01 (p <0.01, <1%) and R2 > 0.95 was adopted. Furthermore, the one-way analysis of variance (ANOVA1) test was applied.

The data were managed via Microsoft Excel version 16.36, for MacOS Catalina version 10.15.4. Statistical assessments were computed by IBM SPSS Statistic Subscription application 1.0.0.1347 64Bits for MacOS. These values were considered statistically significant when (p <0.05, <5%) and the established beta, (β) value was 0.1.

RESULTS

Until the 31st day after the 5th death, the increase in mortality in Brazil and USA follow a similar pattern. The bivariate correlation test was significant with p <0.001 and degree of linear relationship was R2 = 0.99 (Figure 1).

Figure 1:
  • Download figure
  • Open in new tab
Figure 1:

Deaths associated to COVID-19 in Brazil and USA.

In Brazil, the mathematical models attempted to estimate the mortality curve in absolute values, from the 5th to the 30th death (April 17th 2020) and the models that came nearest were the cubic and the quadratic, as illustrated in Figure 2.

Figure 2:
  • Download figure
  • Open in new tab
Figure 2:

Total deaths related to COVID-19 in Brazil.

Nevertheless, as illustrated in Table 1, the cubic model fits best, R2 = 0.998.

Consequently, the cubic model, thus far, best fits an approximation of the growth curve of mortality owing to COVID-19 in Brazil and is in the following manner:

Embedded Image
View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 1:

Model summary and parameter estimates.

Where t is the number of days from the 5th death.

With regards this mathematical model, it was demonstrated in Figure 3 that the estimation of total deaths for Brazil, assuming no behavioral changes amongst the population for the 50th day after the 5th death is 9,312 deaths by COVID-19.

Figure 3:
  • Download figure
  • Open in new tab
Figure 3:

Comparison between total deaths related to COVID-19 in Brazil and projected via mathematical model.

DISCUSSION

Our brief report was commenced to assess the level of COVID-19 related deaths in Brazil and USA. This intention was explained so as to estimate the possibility of Brazil becoming the next pandemic global epicenter. Our results described significant connections between Brazil and USA about total mortality related to COVID-19 up until the 31st day after the 5th death.

The main concern regarding this mathematical forecast is to enable data to permit the Brazilian government to format policies to protect its own population.

Our study highlights some problems which need addressing. Some Brazilian states, including Sao Paulo, reported only a few COVID-19 cases (Sao Paulo sanctions warnings only in severe cases of COVID-19 and declares that it maintains advice from the Brazilian Ministry of Health), we emphasize the potential of the under reporting of cases.

In summary, the mathematical model enforced in Brazil and USA advocates that Brazil may be the next global pandemic epicenter. We encourage adherence to Brazilian public guidelines to reduce the impact of COVID-19 in Brazil.

Data Availability

The data are available at www.worldometer.info

http://www.worldometer.info

AUTHOR CONTRIBUTIONS

Pedro de Lemos Menezes draft the manuscript, wrote introduction and discussion section gave final approval for the version submitted for publication.

David M. Garner draft the manuscript, performed statistical analysis and improved interpretation analysis, reviewed English Grammar and Spelling.

Vitor E. Valenti draft the manuscript, wrote introduction and discussion section and gave final approval for the version submitted for publication.

COMPETING INTERESTS

The authors declare absence of financial and non-financial interests.

ACKNOWLEDGMENTS

Authors thank the technical staff from Sao Paulo State University, UNESP/Marilia, SP, Brazil and University of Health Sciences of Alagoas, AL, Brazil. Dr. Vitor receives financial support from FAPESP (Process number 2012/01366-6) financial support from the National Council for Scientific and Technological Development, an entity linked to the Ministry of Science, Technology, Innovations and Communications from Brazil (Process number 302197/2018-4).

REFERENCES

  1. ↵
    Angelos, G., Dockter, A.G., Gachabayov, M., Latifi, R., Bergamaschi, R. (2020). Emergency Colorectal Surgery in a COVID-19 Pandemic Epicenter. Surg. Technol. Int. 36. pii: sti36/1297.
  2. No authors listed. (2020). Stop the Wuhan virus. Nature 577, 450. doi: 10.1038/d41586-020-00153-x
    OpenUrlCrossRef
  3. No author listed. (2020). Europe now centre of pandemic, says WHO. Nature. 13 March 22:00 GMT.
  4. SP keeps notification only for severe cases of coronavirus and says it follows Brazilian Ministery of Health. G1. Assessed on April 13th 2020: https://g1.globo.com/sp/sao-paulo/noticia/2020/04/08/sp-mantem-notificacao-apenas-para-casos-graves-de-coronavirus-e-diz-que-segue-ministerio-da-saude.ghtml
Back to top
PreviousNext
Posted May 05, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
BRAZIL IS PROJECTED TO BE THE NEXT GLOBAL COVID-19 PANDEMIC EPICENTER
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
BRAZIL IS PROJECTED TO BE THE NEXT GLOBAL COVID-19 PANDEMIC EPICENTER
Pedro de Lemos Menezes, David M. Garner, Vitor E. Valenti
medRxiv 2020.04.28.20083675; doi: https://doi.org/10.1101/2020.04.28.20083675
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
BRAZIL IS PROJECTED TO BE THE NEXT GLOBAL COVID-19 PANDEMIC EPICENTER
Pedro de Lemos Menezes, David M. Garner, Vitor E. Valenti
medRxiv 2020.04.28.20083675; doi: https://doi.org/10.1101/2020.04.28.20083675

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Health Systems and Quality Improvement
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1101)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (502)
  • Epidemiology (9782)
  • Forensic Medicine (5)
  • Gastroenterology (481)
  • Genetic and Genomic Medicine (2318)
  • Geriatric Medicine (223)
  • Health Economics (463)
  • Health Informatics (1563)
  • Health Policy (737)
  • Health Systems and Quality Improvement (606)
  • Hematology (238)
  • HIV/AIDS (507)
  • Infectious Diseases (except HIV/AIDS) (11656)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (239)
  • Medical Ethics (67)
  • Nephrology (258)
  • Neurology (2148)
  • Nursing (134)
  • Nutrition (338)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (518)
  • Oncology (1183)
  • Ophthalmology (366)
  • Orthopedics (129)
  • Otolaryngology (220)
  • Pain Medicine (148)
  • Palliative Medicine (50)
  • Pathology (313)
  • Pediatrics (698)
  • Pharmacology and Therapeutics (302)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2188)
  • Public and Global Health (4673)
  • Radiology and Imaging (781)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (624)
  • Rheumatology (274)
  • Sexual and Reproductive Health (226)
  • Sports Medicine (210)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)